| Market Cap | €1.98B | |
| Enterprise Value | €3.76B | |
| Revenue | — | — |
| Gross Profit | — | — |
| EBITDA | — | — |
| Net Income | €245.2M | −0.2% |
| Diluted EPS | €9.56 | −4.0% |
| Free Cash Flow | €198.8M | +14.6% |
| DPS (FY2025) | — |
| Trailing yield | — |
| Payout ratio | 26.7% |
| Growth streak | — |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20252025-12-31 | — | — | reported |
| FY20242024-12-31 | — | — | reported |
| FY20232023-12-31 | — | — | reported |
| FY20222022-12-31 | — | — | reported |
| Ratio | 2022 | 2023 | 2024 | 2025 | Trend · 4y | vs own |
|---|---|---|---|---|---|---|
| ▾Returns on Capital | ||||||
| Return on Equity | 4.34% | −12.83% | 11.94% | 10.58% | 63% | |
| Return on Assets | — | −6.19% | 5.90% | 5.69% | 50% | |
| Cash ROIC | — | 4.65% | 4.38% | 4.81% | 83% | |
| ▸DuPont factors (ROE drivers) · 1 ratios | ||||||
| ▸Earnings quality · 3 ratios | ||||||
| ▸Liquidity & coverage · 3 ratios | ||||||
| ▸Leverage · 6 ratios | ||||||
| ▸Capital allocation · 3 ratios | ||||||
| Line | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating Income | €116.8M | -€201.2M | €302.2M | €290.9M |
| YoY % | -3.8% | |||
| Equity Method Income | -€32,000 | €13,000 | €50,000 | -€27,000 |
| YoY % | +284.6% | |||
| Income Tax | €33,000 | €0 | €0 | €0 |
| YoY % | -100.0% | |||
| Net Income (incl. NCI) | €94.9M | -€266.4M | €249.6M | €248.0M |
| YoY % | -0.6% | |||
| Minority Interest (P&L) | -€221,000 | -€3.0M | €3.9M | €2.8M |
| YoY % | -28.1% | |||
| Net Income | €95.1M | -€263.4M | €245.7M | €245.2M |
| YoY % | -0.2% | |||
| EPS (Basic) | €4.14 | -€11.44 | €9.96 | €9.57 |
| YoY % | -3.9% | |||
| EPS (Diluted) | €4.17 | -€11.43 | €9.96 | €9.56 |
| YoY % | -4.0% |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
